News about Global Pharma

Zydus and Synthon Sign Exclusive Licensing and Supply Agreement for Ozanimod Capsules for US Market

Zydus Lifesciences’ subsidiary Zydus Lifesciences Global FZE has signed an exclusive licensing and supply deal with Synthon BV to commercialise generic Ozanimod Capsules (ZEPOSIA) in the US market.

Global Pharma | 05/09/2025 | By Mrinmoy Dey |  194

NAYA Therapeutics Partners with Atley Solutions on Astatine-211 Radio Pharmaceuticals

NAYA Therapeutics will leverage Atley’s clinical manufacturing network and establish additional GMP sites using the Atley C100 for the final clinical-dose manufacturing of 211 At Targeted Alpha Therapies.

Global Pharma | 04/09/2025 | By Dineshwori |  379

Cayman Chemical, Curapath Join Forces to Expand Access to PEG-Free Shielding Lipids for LNPs

Cayman Chemical and Curapath have partnered to make PEG-free shielding lipids available to researchers advancing LNPs for non-viral drug delivery, gene therapy, mRNA vaccines, and biologic therapies.

Global Pharma | 04/09/2025 | By Mrinmoy Dey |  219

Lupin Secures US FDA Approval for Risperidone Long-Acting Injectable

Lupin has received US FDA approval for its Risperidone extended-release injectable suspension, marking the first product from its Nanomi long-acting injectables platform with 180-day CGT exclusivity.

Global Pharma | 03/09/2025 | By Mrinmoy Dey |  151

Quotient Sciences and CPI to Form JV to Accelerate RNA Drug Development

Quotient Sciences and UK innovation centre CPI have signed an MoU to form a joint venture that will accelerate the development of RNA-based therapies through an integrated, end-to-end platform.

Global Pharma | 03/09/2025 | By Mrinmoy Dey |  262

SeqOne Strengthens UK Presence with Acquisition of Congenica

The acquisition of UK genomics leader Congenica strengthens SeqOne’s market position and global footprint, servicing over 160 labs in more than 30 countries.

Global Pharma | 03/09/2025 | By Dineshwori |  138

LOTTE BIOLOGICS Enters Contract Manufacturing Partnership with US Biopharma

South Korea’s LOTTE BIOLOGICS has signed a late-stage to commercial contract manufacturing agreement with a US-based global biopharmaceutical company.

Global Pharma | 02/09/2025 | By Dineshwori |  437

Servier and IDEAYA Biosciences Collaborate to Advance Darovasertib, a Potential Uveal Melanoma Therapy, Globally

Servier and IDEAYA Biosciences have entered into an exclusive license agreement to globally develop and commercialise darovasertib, a potential first-in-class therapy for uveal melanoma, with Servier taking rights outside the US and IDEAYA retaining US rights.

Global Pharma | 02/09/2025 | By Mrinmoy Dey |  221

Remedium Lifecare Unveils 4-Point Growth Strategy

Remedium Lifecare Ltd. has unveiled a 4-point strategic roadmap – spanning advanced manufacturing, global expansion, R&D innovation, and product diversification.

Global Pharma | 02/09/2025 | By Mrinmoy Dey |  167

Asston Pharmaceuticals Secures International Supply Order Worth INR 2.65 Crore

Asston Pharmaceuticals has received an order from a leading international pharmaceutical company to supply a range of pharma products worth INR 2.65 crore

Global Pharma | 02/09/2025 | By Dineshwori |  211